Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- Pembro in Patients With HR+/HER2- mBC"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ana Garrido-Castro
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Ana Garrido-Castro
274 views
June 13, 2024
Chapters
SACI-IO HR+ Trial Overview
00:00
Clinical Trial Results & Patient Data
02:35
Safety Profile & Concluding Remarks
05:36
Comments 0
Login to view comments.
Click here to Login